CTCF and cancer: Results indicated that the CBFB, E2F1, E2F6, FOXM1, HDAC1, HDAC2, SMC1A, CTCF, and RAD21 transcription factors were consistently positive in more than 20 types of cancers and were predicted to be the potential targets of RRM2.